Abstract

Migraine attacks are delimited, allowing investigation of changes during and outside attack. Gene expression fluctuates according to environmental and endogenous events and therefore, we hypothesized that changes in RNA expression during and outside a spontaneous migraine attack exist which are specific to migraine. Twenty-seven migraine patients were assessed during a spontaneous migraine attack, including headache characteristics and treatment effect. Blood samples were taken during attack, two hours after treatment, on a headache-free day and after a cold pressor test. RNA-Sequencing, genotyping, and steroid profiling were performed. RNA-Sequences were analyzed at gene level (differential expression analysis) and at network level, and genomic and transcriptomic data were integrated. We found 29 differentially expressed genes between ‘attack’ and ‘after treatment’, after subtracting non-migraine specific genes, that were functioning in fatty acid oxidation, signaling pathways and immune-related pathways. Network analysis revealed mechanisms affected by changes in gene interactions, e.g. ‘ion transmembrane transport’. Integration of genomic and transcriptomic data revealed pathways related to sumatriptan treatment, i.e. ‘5HT1 type receptor mediated signaling pathway’. In conclusion, we uniquely investigated intra-individual changes in gene expression during a migraine attack. We revealed both genes and pathways potentially involved in the pathophysiology of migraine and/or migraine treatment.

Details

Title
Changes in the gene expression profile during spontaneous migraine attacks
Author
Kogelman Lisette J A 1 ; Falkenberg Katrine 1 ; Buil Alfonso 2 ; Erola Pau 3 ; Courraud Julie 4 ; Laursen, Susan Svane 4 ; Michoel Tom 5 ; Olesen Jes 1 ; Hansen, Thomas F 6 

 Rigshospitalet Glostrup, Danish Headache Center, Department of Neurology, Glostrup, Denmark (GRID:grid.475435.4) 
 Mental Health Center Sct. Hans, Institute for Biological Psychiatry, Roskilde, Denmark (GRID:grid.475435.4) 
 University of Bristol, MRC Integrative Epidemiology Unit, Bristol, UK (GRID:grid.5337.2) (ISNI:0000 0004 1936 7603) 
 Statens Serum Institute Copenhagen, Department of Clinical Biochemistry and Immunology, Copenhagen, Denmark (GRID:grid.6203.7) (ISNI:0000 0004 0417 4147) 
 University of Bergen, Computational Biology Unit, Department of Informatics, Bergen, Norway (GRID:grid.7914.b) (ISNI:0000 0004 1936 7443) 
 Rigshospitalet Glostrup, Danish Headache Center, Department of Neurology, Glostrup, Denmark (GRID:grid.475435.4); Mental Health Center Sct. Hans, Institute for Biological Psychiatry, Roskilde, Denmark (GRID:grid.475435.4); Copenhagen University, Novo Nordisk Foundation Centre for Protein Research, Copenhagen, Denmark (GRID:grid.5254.6) (ISNI:0000 0001 0674 042X) 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2513091866
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.